Unlocking the Therapeutic Power of Self-Amplifying & Circular RNA for Longer Expression & Lower Dosing

• Discovering how saRNA and circRNA are redefining RNA’s potential with longer lasting expression, lower dosing, and expanded therapeutic applications
• Understanding the scientific and clinical implications of modality-specific challenges, from immunogenicity to delivery complexity
• Learning from pioneering case studies translating next-generation RNA formats into viable therapies across oncology, rare diseases, and beyond

Speakers:

Bo Ying

Chief Executive Officer

AboGen